-
Something wrong with this record ?
Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system
D. Kuzel, Z. Lisa, M. Fanta, Z. Zizka, B. Boudova, T. Cindrova-Davies, M. Mara
Language English Country Great Britain
Document type Journal Article
NLK
CINAHL Plus with Full Text (EBSCOhost)
from 2008-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2001-01-01 to 1 year ago
- MeSH
- Uterine Hemorrhage MeSH
- Leiomyoma * drug therapy surgery MeSH
- Levonorgestrel therapeutic use MeSH
- Humans MeSH
- Uterine Neoplasms * drug therapy surgery MeSH
- Intrauterine Devices, Medicated * MeSH
- Polyps * drug therapy surgery MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
INTRODUCTION: This study was designed to evaluate the feasibility and effectiveness of hysteroscopy in the management of symptoms related to endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system (LNG-IUS). MATERIAL AND METHODS: Twenty-three LNG-IUS users presenting with endometrial polyps and/or submucous leiomyomas and irregular uterine bleeding were recruited for hysteroscopic examination and surgery. Intrauterine pathology was investigated and treated by hysteroscopic resection with the LNG-IUS in situ, and the effect of the procedure on symptoms was evaluated after three to six months. RESULTS: Intrauterine pathology was successfully resected by hysteroscopy in 23 (100.0%) out of 23 cases. Following hysteroscopy, 18 (78.3%) women reported amenorrhea, one (4.3%) regular spotting, three (13.0%) irregular spotting and one (4.3%) patient resumed normal menstrual cycle. We conclude that 19 (82.6%) patients were postoperatively asymptomatic. All procedures were uncomplicated and 4 (17.4%) were carried out without general anesthesia as office procedures. CONCLUSION: Endometrial polyps and submucous leiomyomas can develop in LNG-IUS users, and this can cause irregular uterine bleeding. Hysteroscopic resection of these pathologies is a feasible method in the clinical management of symptoms.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019025
- 003
- CZ-PrNML
- 005
- 20220804135257.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/13645706.2020.1870499 $2 doi
- 035 __
- $a (PubMed)33428484
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kuzel, David $u Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic
- 245 10
- $a Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system / $c D. Kuzel, Z. Lisa, M. Fanta, Z. Zizka, B. Boudova, T. Cindrova-Davies, M. Mara
- 520 9_
- $a INTRODUCTION: This study was designed to evaluate the feasibility and effectiveness of hysteroscopy in the management of symptoms related to endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system (LNG-IUS). MATERIAL AND METHODS: Twenty-three LNG-IUS users presenting with endometrial polyps and/or submucous leiomyomas and irregular uterine bleeding were recruited for hysteroscopic examination and surgery. Intrauterine pathology was investigated and treated by hysteroscopic resection with the LNG-IUS in situ, and the effect of the procedure on symptoms was evaluated after three to six months. RESULTS: Intrauterine pathology was successfully resected by hysteroscopy in 23 (100.0%) out of 23 cases. Following hysteroscopy, 18 (78.3%) women reported amenorrhea, one (4.3%) regular spotting, three (13.0%) irregular spotting and one (4.3%) patient resumed normal menstrual cycle. We conclude that 19 (82.6%) patients were postoperatively asymptomatic. All procedures were uncomplicated and 4 (17.4%) were carried out without general anesthesia as office procedures. CONCLUSION: Endometrial polyps and submucous leiomyomas can develop in LNG-IUS users, and this can cause irregular uterine bleeding. Hysteroscopic resection of these pathologies is a feasible method in the clinical management of symptoms.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nitroděložní tělíska hormonální $7 D007436
- 650 12
- $a leiomyom $x farmakoterapie $x chirurgie $7 D007889
- 650 _2
- $a levonorgestrel $x terapeutické užití $7 D016912
- 650 12
- $a polypy $x farmakoterapie $x chirurgie $7 D011127
- 650 _2
- $a děložní krvácení $7 D014592
- 650 12
- $a nádory dělohy $x farmakoterapie $x chirurgie $7 D014594
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lisa, Zdenka $u Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Fanta, Michael $u Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000287592533 $7 xx0106843
- 700 1_
- $a Zizka, Zdenek $u Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Boudova, Barbora $u Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000304447160
- 700 1_
- $a Cindrova-Davies, Tereza $u Department of Physiology, Development and Neuroscience, St John's College Teaching Associate, University of Cambridge, Centre for Trophoblast Research, Cambridge, UK
- 700 1_
- $a Mara, Michal $u Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00003375 $t Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy $x 1365-2931 $g Roč. 31, č. 4 (2022), s. 615-619
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33428484 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135251 $b ABA008
- 999 __
- $a ok $b bmc $g 1822574 $s 1170268
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 31 $c 4 $d 615-619 $e 20210111 $i 1365-2931 $m Minimally invasive therapy & allied technologies $n Minim Invasive Ther Allied Technol $x MED00003375
- LZP __
- $a Pubmed-20220720